These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6728045)

  • 41. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
    Aoki N; Johnson G; Lefer AM
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of dopamine on liver dynamics in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Circ Shock; 1977; 4(4):305-15. PubMed ID: 598004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathophysiology of shock.
    Okada K; Kosugi I; Kitagaki T; Yamaguchi Y; Yoshikawa H
    Jpn Circ J; 1977 Apr; 41(4):346-61. PubMed ID: 875220
    [No Abstract]   [Full Text] [Related]  

  • 44. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock.
    Johnson G; Lefer AM
    Circ Shock; 1990 Feb; 30(2):155-64. PubMed ID: 2311204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock.
    Bitterman H; Aoki N; Lefer AM
    Proc Soc Exp Biol Med; 1988 Jul; 188(3):265-71. PubMed ID: 3393543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on the anti-shock mechanism of anisodamine. II. Dynamic change in blood histamine during endotoxic shock and effect of anisodamine on hypotensive effect of histamine].
    Chen XY; Xi PX; Yan YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):385-7. PubMed ID: 6233024
    [No Abstract]   [Full Text] [Related]  

  • 47. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM; Lefer DJ; Levin RJ
    Adv Shock Res; 1980; 3():167-74. PubMed ID: 6118024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective actions of naloxone in hemorrhagic shock.
    Curtis MT; Lefer AM
    Am J Physiol; 1980 Sep; 239(3):H416-21. PubMed ID: 7435587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective action of 6-keto-prostaglandin E1 in traumatic shock.
    Araki H; Lefer AM
    Prostaglandins Med; 1979 Apr; 2(4):277-84. PubMed ID: 575862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats.
    Zou AP; Parekh N; Steinhausen M
    Int J Microcirc Clin Exp; 1990 Aug; 9(3):285-96. PubMed ID: 2394549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor.
    Liu C; Shen FM; Le YY; Kong Y; Liu X; Cai GJ; Chen AF; Su DF
    Crit Care Med; 2009 Feb; 37(2):634-41. PubMed ID: 19114896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mechanism of the antishock action of anisodamine (654-2)].
    Su JY
    Sheng Li Ke Xue Jin Zhan; 1985 Oct; 16(4):317-22. PubMed ID: 3915591
    [No Abstract]   [Full Text] [Related]  

  • 55. Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock.
    Symington PA; Ma XL; Lefer AM
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):789-97. PubMed ID: 1338473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA; Lefer AM
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock.
    Bitterman H; Lefer AM
    Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):63-70. PubMed ID: 3406041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A; Rochester JA; Lefer AM
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.